Effects of siRNA-mediated knockdown of jumonji domain containing 2A on proliferation, migration and invasion of the human breast cancer cell line MCF-7

Experimental and Therapeutic Medicine

Volumn 4, Issue 4, 2012, Pages 755-761

  Li, Bei Xu ^a   Luo, Cheng Liang ^a   Li, Hui ^a   Yang, Peng ^a   Zhang, Ming Chang ^a   Xu, Hong Mei ^a   Xu, Hong Fei ^a   Shen, Yi Wen ^a   Xue, Ai Min ^a   Zhao, Zi Qin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Invasion; Jumonji domain containing 2A; Migration; Proliferation; Transfection

Indexed keywords

HISTONE DEMETHYLASE; JUMONJI DOMAIN CONTAINING 2A PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; DOWN REGULATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84865361731     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.662     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Sen GL and Blau HM: A brief history of RNAi: the silence of the genes. FASEB J 20: 1293-1299, 2006.
3. Katoh M and Katoh M: Identification and characterization of JMJD2 family genes in silico. Int J Oncol 24: 1623-1628, 2004.
4. Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E and Dangond F: Functional characterization of JMJD2A, a histone deacetylase-and retinoblastoma-binding protein. J Biol Chem 280: 28507-28518, 2005.
5. Shin S and Janknecht R: Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun 359: 742-746, 2007.
6. Trojer P and Reinberg D: Histone lysine demethylases and their impact on epigenetics. Cell 125: 213-217, 2006.
7. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M and Shi Y: Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125: 467-481, 2006.
8. Nottke A, Colaiácovo MP and Shi Y: Developmental roles of the histone lysine demethylases. Development 136: 879-889, 2009.
9. Zhang XD, Wang Y, Wang Y, Zhang X, Han R, Wu JC, LiangZQ, Gu ZL, Han F, Fukunaga K and Qin ZH: p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 5: 339-350, 2009.
10. Luo CL, Li BX, Li QQ, Chen XP, Sun YX, Bao HJ, Dai DK, ShenYW, Xu HF, Ni H, et al: Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice. Neuroscience 184: 54-63, 2011.
11. Dai HY, Liu L, Qin SK, He XM and Li SY: Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO invitro. Biomed Pharmacother 65: 137-141, 2011.
12. Tang Y, Huang B, Sun L, Peng X, Chen X and Zou X: Ginkgolide B promotes proliferation and functional activities of bone marrow-derived endothelial progenitor cells: involvement of Akt/eNOS and MAPK/p38 signaling pathways. Eur Cell Mater 21: 459-69, 2011.
13. Li L, Zhang C, Li X, Lu S and Zhou Y: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. J Exp Clin Cancer Res 29: 133, 2010.
14. Jovanovic J, Rønneberg JA, Tost J and Kristensen V: The epigenetics of breast cancer. Mol Oncol 4: 242-254, 2010.
15. Martin C and Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838-849, 2005.
16. Müller-Tidow C, Klein HU, Hascher A, Isken F, TickenbrockL, Thoennissen N, Agrawal-Singh S, Tschanter P, DisselhoffC, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, SchlenkeP, McClelland M, Berdel WE, Dugas M, Serve H; Study Alliance Leukemia: Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood 116: 3564-3571, 2010.
17. Cloos PA, Christensen J, Agger K and Helin K: Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 22: 1115-1140, 2008.
18. Schübeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, Bell SP and Groudine M: The histone modification pattern of active genes revealed through genome-wide chromatin analysis of higher eukaryote. Genes Dev 18: 1263-1271, 2004.
19. Shilatifard A: Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75: 243-269, 2006.
20. Xu D, Bai J, Duan Q, Costa M and Dai W: Covalent modifications of histones during mitosis and meiosis. Cell Cycle 8: 3688-3694, 2009.
21. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, et al: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560, 2007.
22. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, WeiG, Chepelev I and Zhao K: High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837, 2007.
23. Brinkman AB, Roelofsen T, Pennings SW, Martens JH, JenuweinT, and Stunnenberg HG: Histone modification patterns associated with the human X chromosome. EMBO Rep 7: 628-634, 2006.
24. Vakoc CR, Mandat SA, Olenchock BA and Blobel GA. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell 19: 381-391, 2005.
25. Gomes NP and Espinosa JM: Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev 24: 1022-1034, 2010.
26. Peters AH, O'Carroll D, Scherthan H, Mechtler K, SauerS, SchöferC, Weipoltshammer K, Pagani M, Lachner M, KohlmaierA, et al: Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337, 2001.
27. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T and SchmittCA: Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665, 2005.
28. Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW and Okada H: Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 6: e17830, 2011.
29. Takaki T, Fukasawa K, Suzuki-Takahashi I and Hirai H. Cdk-mediated phosphorylation of pRB regulates HDAC binding invitro. Biochem Biophys Res Commun 316: 252-255, 2004.
30. Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, ThebergeMC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, et al: RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol 21: 2918-2932, 2001.
31. Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, HelinK, Liao WS and Yu Y: E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene 25: 230-239, 2006.
32. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, KuoWL, Gray JW, Siciliano M, Mills GB and Bast RC Jr: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214-219, 1999.